Post by
DamnYankees on Sep 30, 2015 5:33pm
Maybe another Phase 3 is required?
That would delay things for several more years. I wonder if this speculation is the reason for the sell off after the New York broker presentation??? What else would explain the drop? I read the presentation to mean that the FDA changes from 2013 meant that the first trial was sufficient for approval but I could be wrong even though I think that is what they were implying. If that is the case I hope that they start the trial work as soon as possible. Maybe another US financing will come with the consolidation? Then they would need more options to ensure insiders are not diluted but that is to be expected.
Comment by
HighteawithIntrepid on Sep 30, 2015 8:40pm
So how long have you been colour blind? 60 days to ADCOMM until then find a hobby.
Comment by
txbioinv on Oct 01, 2015 12:00pm
DY, why don't you call the COO and ask him when the next phase 3 starts? .......either your betting short, need more shares, or have no clue about biotech investing and/or how the FDA works. You have totally insulted the good Dr and all his team. You are a total jaaaackaaarssse. GL serious longtimers
Comment by
DamnYankees on Oct 01, 2015 3:05pm
I am sorry about my bad behaviour TXB. But you know I felt moderately "insulted" when 108 mil shares were diluted out at 34 cents a week or thereabout before the "priority review" news. Thicker skin could go along way here.
Comment by
txbioinv on Oct 01, 2015 8:20pm
My apologies for the remark to you; I guess we all need a little patience around here. We are getting close. Keep adding if you can . I decided to add another 10K, what the hell............. GL longtimers
Comment by
cheetio on Oct 02, 2015 7:57am
Maybe another US financing will come with the consolidation? .......hey ...pumping another chapter into a fairytale book ain't free